DQB1 alleles distribution in patients with self-limiting HCV acute infection (SLI), with persistent HCV infection (PI) and in controls
| Allele | SLI | PI | Controls | SLI v PI | SLI v controls | PI v controls | SLI+PI v controls | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DQB1 | (n = 10) | (n = 24) | (n = 40) | p | pc | p | pc | p | pc | p | pc |
| NS, not significant. | |||||||||||
| *02 | 4 (40%) | 9 (37.5%) | 8 (20%) | NS | NS | NS | NS | ||||
| *0301 | 4 (40%) | 15 (62.5%) | 27 (67.5%) | NS | NS | NS | NS | ||||
| *0302 | 2 (20%) | 4 (16.7%) | 3 (7.5%) | NS | NS | NS | NS | ||||
| *0303 | 2 (20%) | 2 (8.3%) | 2 (5%) | NS | NS | NS | NS | ||||
| *05 | 6 (60%) | 8 (33.3 %) | 12 (30%) | NS | NS | NS | NS | ||||
| *0501 | 2 (20%) | 2 (8.3%) | 6 (15%) | NS | NS | NS | NS | ||||
| *0502 | 2 (20%) | 3 (12.5%) | 5 (12.5%) | NS | NS | NS | NS | ||||
| *0503 | 2 (20%) | 3 (12.5%) | 1 (2.5%) | NS | NS | NS | NS | ||||
| *06 | 1 (10%) | 5 (20.8%) | 12 (30%) | NS | NS | NS | NS | ||||